Wpływ płci na zalecanie doustnej antykoagulacji w prewencji powikłań zakrzepowo-zatorowych u chorych z migotaniem przedsionków: rejestr 4099 chorych z referencyjnego ośrodka kardiologicznego
Authors:
Open Access
- 13 February 2019
- journal article
- Published by VM Media Group sp. z o.o in Folia Cardiologica
- Vol. 13 (6) , 510-516
Abstract
Atrial fibrillation (AF) is the most common supraventricular arrhythmia. AF is characterised by disorganised atrial activation which leads to an impairment of atrial haemodynamic function and, in turn, to serious clinical consequences such as increased risks of heart failure, thromboembolism, and death. AF prevalence increases with age; in people aged < 50 years, the prevalence is 0.1%, whereas in those aged > 85 years it is 17.8%. Although men have a higher risk of AF compared to women, in women, AF more often is symptomatic and associated with more serious complications. Because female sex is a risk factor for thromboembolism, in 2012 the European Society of Cardiology recommended the use of the CHA2DS2-VASc score, which scores 1 point for being female, in assessing the thromboembolic risk in patients with AF. Among hospitalised patients with AF (men and women), this study assessed the thromboembolic risk and evaluated anticoagulant use for stroke prevention. Atrial fibrillation (AF) is the most common supraventricular arrhythmia. AF is characterised by disorganised atrial activation which leads to an impairment of atrial haemodynamic function and, in turn, to serious clinical consequences such as increased risks of heart failure, thromboembolism, and death. AF prevalence increases with age; in people aged < 50 years, the prevalence is 0.1%, whereas in those aged > 85 years it is 17.8%. Although men have a higher risk of AF compared to women, in women, AF more often is symptomatic and associated with more serious complications. Because female sex is a risk factor for thromboembolism, in 2012 the European Society of Cardiology recommended the use of the CHA2DS2-VASc score, which scores 1 point for being female, in assessing the thromboembolic risk in patients with AF. Among hospitalised patients with AF (men and women), this study assessed the thromboembolic risk and evaluated anticoagulant use for stroke prevention.Keywords
This publication has 18 references indexed in Scilit:
- Sex and Gender Differences in Thromboprophylactic Treatment of Patients With Atrial Fibrillation After the Introduction of Non–Vitamin K Oral AnticoagulantsThe American Journal of Cardiology, 2017
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEuropean Heart Journal, 2012
- Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial FibrillationJAMA, 2012
- Practice-Level Variation in Warfarin Use Among Outpatients With Atrial Fibrillation (from the NCDR PINNACLE Program)The American Journal of Cardiology, 2011
- Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registryClinical Research in Cardiology, 2011
- The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial managementEP Europace, 2008
- Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyEuropean Heart Journal, 2006
- Atrial fibrillation management: a prospective survey in ESC Member CountriesEuropean Heart Journal, 2005
- A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the CommunityJAMA, 2003
- Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and OpportunitiesNew England Journal of Medicine, 1997